The hyaluronate lyase (HL) gene of Staphylococcus aureus 8325-4 (hysA) was inactivated in vitro with the insertion of the erythromycin determinant, ermC, from plasmid pE194. The hysA : : ermC mutation was introduced into S. aureus via a temperature-sensitive shuttle vector, where it underwent homologous recombination with the wild-type (w.t.) allele. The insertion of ermC in the chromosomal hysA locus was confirmed by Southern blot hybridization and the loss of HL activity was demonstrated macroscopically by a plate assay. The importance of HL for pathogenicity was assessed by comparing the virulence of the HL " mutant strain to that of the w.t. in an established mouse abscess model of S. aureus infection. A significantly higher cell recovery was obtained from lesions infected with the w.t. strain compared to the lesions infected with the HL " strain (P =0?01). Although the lesion areas from both groups were not significantly different (P=0?9) they were of different morphology. A colorimetric assay was used to measure HL activity from culture supernatants of the S. aureus 8325-4 strains w.t., WA250 (agr) and PC1839 (sar) grown in a chemically defined medium. HL activity reached a maximum in the w.t. strain during mid-exponential phase (t=5 h) and while it showed a 16-fold decrease in the agr mutant it increased 35-fold in the sar mutant background. These results strongly suggest that HL is a virulence factor which is important in the early stages of subcutaneous infections.
INTRODUCTION
The human and animal pathogen Staphylococcus aureus represents a major cause of infection. This organism possesses a formidable range of gene products which allow it to colonize the host, invade through minor breaks in skin and mucous membranes, disseminate through the body, cause overt pathology, and evade host defence mechanisms. As many as 30 potential virulence determinants have been described for this pathogen, with a wide range of biological activities. It is generally held that no single virulence factor is responsible for the pathogenicity of staphylococci, and that disease occurs in vivo due to a complex series of processes, with the appropriate pathogenic factors being present at each stage (Jeljaszewicz, 1983) . The enzyme hyaluronate lyase (HL) represents such a factor. HL, a long-neglected potential virulence determinant of S. aureus, is produced by the organism as an extracellular enzyme capable of degrading the acidic mucopolysaccharide hyaluronic acid (HA), a major component of the intercellular ground substance of human and animal connective tissue (Arvidson, 1983) . Duran-Reynals (1933) observed that culture extracts of S. aureus increased permeability of rabbit tissue to vaccinia virus, toxins and dyes. Subsequently, the 'spreading factor' was identified as a HL (Linker et al., 1955) . A study (Pritchard & Lin, 1993) with group B streptococci (GBS), indicated that the enzyme, previously reported to be a neuraminidase, was in fact a HL. Clearly, previous reports describing an association of elevated levels of this enzyme with virulent strains of GBS add support to the hypothesis that HL is also a virulence factor of staphylococci. In addition, the observation that 91?2 % of S. aureus strains produce HL (Choudhuri & Chakrabarty, 1969) strengthens the case for a role in virulence. The production of HL from other staphylococcal strains is either negative or variable, though Staphylococcus hyicus is positive for HL production and is also an opportunistic pathogen in animals (Devriese, 1990) .
Studies on HL regulation were previously initiated by Taylor & Holland (1991) . In addition the HL gene, hysA, has been previously cloned from a genomic library of S. aureus (Farrell et al., 1995) . The present investigation was undertaken in order to assess the importance of HL in the virulence of S. aureus in vivo. A mutant deficient in HL activity was compared with wild-type S. aureus, using an animal model. The roles of the S. aureus global regulators, agr and sar, on the in vitro production of HL were also investigated. In the longer term such studies are relevant to the potential future of research directed at designing agents which interfere with virulence determinant expression in this important pathogen.
METHODS
Bacterial strains, plasmids and culture conditions. S. aureus and Escherichia coli strains and plasmids used in this study are listed in Table 1 . For cloning and DNA manipulations in E. coli, strain XL-1 Blue (Stratagene) was used. To enable transfer of recombinant DNA to S. aureus from E. coli, plasmids were passaged through S. aureus RN4220 (Kreiswirth et al., 1983) , a restriction-deficient strain derived from S. aureus 8325-4 (Novick, 1967) . E. coli was grown at 37 uC with shaking at 160 r.p.m. in Luria-Bertani (LB) medium (Oxoid) and at a culture : flask volume ratio of 0?2 : 1. S. aureus was grown at 37 uC with shaking at 160 r.p.m. in brainheart infusion (BHI) medium (Oxoid), or in a modification of the chemically defined medium (CDM) of Taylor & Holland (1989) . The components of CDM are (concentrations in mg l 21 in parentheses): L-tryptophan (41?2), L-cystine (165), L-methionine (124), L-niacin (119?4), L-thiamin (6), L-lysine (400), L-arginine (247), L-glutamic acid (1650), L-histidine (330), L-aspartic acid (1650), L-threonine (1650), L-serine (1650), L-proline (1650), L-glycine (1650), L-alanine (1650), L-valine (330), L-isoleucine (400), L-leucine (400), L-tyrosine (1240), L-phenylalanine (140) O (0?595) . DL-Lactate was dissolved in CDM at a final concentration of 50 mM. CDM was filter-sterilized using 0?45 mm filters. S. aureus starter cultures were grown at the same culture : flask volume ratio as previously. They were used for the inoculation of 100 ml test cultures in 2 l baffled flasks (culture : flask volume ratio 0?05 : 1) to a starting OD 600 of 0?01-0?1. Allelic replacement mutagenesis experiments were performed using tryptone (2 %, w/v), yeast extract (1 %, w/v) and glucose (0?2 %, w/v) (TYEg) medium. Phage transduction experiments were performed using LK broth, containing tryptone (1 %, w/v), yeast extract (0?5 %, w/v), KCl (0?7 %, w/v) and sodium citrate (0?05 %, w/v). LK top and bottom agar were prepared by the addition of 0?7 and 1?0 % (w/v) Agar no. 1 (Oxoid L11) respectively. Antibiotics were added to the media appropriately at the following final concentrations: 100 mg ampicillin (Ap) ml 21 , 10 mg chloramphenicol (Cm) ml 21 , 10 mg erythromycin (Em) ml 21 and 5 mg tetracycline (Tc) ml 21 . LK top and bottom agar contained 25 and 0?15 mg Em ml 21 , respectively. LK top agar was also supplemented with 25 mg lincomycin (Lm) ml 21 .
DNA techniques. All chemicals were purchased from Sigma unless otherwise specified. Procedures for DNA restriction, dephosphorylation and ligation, agarose gel electrophoresis and PCR were performed as described by Sambrook et al. (1989) . Nucleotide sequencing was achieved by the BigDye Terminator cycle reaction (Lark Technologies). For Southern blot hybridizations, digested DNA was transferred onto a Hybond-N + membrane (Roche). DNA probes were labelled using digoxigenin (DIG) (Roche). PCR products and linearized plasmid DNA fragments were extracted from agarose using the JETsorb Gel Extraction kit (Genomed), and were purified with the Qiaquick nucleotide removal kit (Qiagen). Plasmid DNA was prepared from E. coli by the method of Birnboim & Doly (1979) and was transformed into the same organism by the method of Hanahan (1983) . Staphylococcal plasmid DNA was prepared as before, with the substitution of lysostaphin (Sigma) to 50 mg ml 21 in place of lysozyme. Electrocompetent S. aureus cells were prepared and transformed with plasmid DNA as described by Augustin & Götz (1990) . Staphylococcal genomic DNA was prepared as previously described (Pattee & Neveln, 1975; Lindberg et al., 1972) with the following additions. After harvesting, the cells were resuspended in 0?1 vol. EDTA (10 mM) and incubated on ice for 15 min. Lysostaphin and RNase were added to the resuspension buffer to a final concentration of 50 mg ml 21 and the suspension was incubated at 37 uC with gentle agitation for 1?5 h.
Construction of a temperature-sensitive (TS) shuttle plasmid.
Plasmid pUL5032 carries a 2?6 kb EcoRI fragment which contains most of the HL gene's ORF, hysA, with the start site and an 80 bp segment downstream from it missing (Farrell et al., 1995) . A mutation was constructed in this incomplete hysA gene by insertion of the 1?44 kb erythromycin resistance (Em r ) determinant (ermC) from plasmid pE194 (Villafane et al., 1987) . Forward (59-GATCTACGTA-TCGAATTGCATCTG-39; nucleotides 3386 to 3373) and reverse (59-GCAGTACGTAATCGATTCACAAA-39; nucleotides 1937 to 1951) primers were designed according to the published sequence of pE194 (Horinouchi & Weisblum, 1982) , with the additional restriction site NsiI introduced at the 59 end of each primer (underlined). The tails added to the 59 ends of the primers are shown in bold. The amplified ermC fragment was ligated with the PCR vector pCR2.1 (Invitrogen) and the DNA was transformed into E. coli selecting Ap r . The erythromycin-resistance determinant was excised from positive recombinants with NsiI and was ligated with NsiI-digested and dephosphorylated pUL5032. The ligation products were transformed into E. coli selecting Ap r . The desired recombinant plasmid, designated pGM02, was digested with BamHI, dephosphorylated, and ligated with the BamHI-cleaved TS plasmid pTS2tet (Fitzgerald & Foster, 2000) . The DNA was transformed into E. coli selecting Ap r . A 13?5 kb plasmid, designated pGM03, was isolated from putative transformants and was mapped by restriction enzyme analysis. (Farrell et al., 1995) .
Construction of a vector carrying the active hysA gene. A 7?2 kb HindIII fragment containing the full hysA ORF, including upstream regulatory regions, was excised from pUL5030 (Farrell et al., 1995) and following dephosphorylation it was ligated with HindIII-cleaved pCU1 shuttle vector (Augustin et al., 1992) . The ligation mix was transformed into E. coli selecting Ap r . A 12?2 kb plasmid, designated pGM04, was isolated from putative transformants and was mapped by restriction enzyme analysis. Plasmid pGM04 was passaged through S. aureus RN4220 and was then electroporated into electrocompetent HL-deficient cells selecting Em r and Cm r . Several colonies were screened for HL production on Cm plates containing HA.
Phage transduction. This was performed as described by Foster (1998) using w11 (Novick, 1991) as the transducing phage. Briefly, 500 ml of an overnight w.t. S. aureus 8325-4 culture was transferred to a plastic universal containing 500 ml phage lysate (10 9 -10 10 p.f.u. ml 21 ) and 1 ml LK broth. The lysate/cell mixture was incubated at 37 uC without shaking for 25 min, followed by 15 min with shaking at 250 r.p.m. Then 1 ml ice-cold sodium citrate (0?02 M) was added and the cells were pelleted at 5000 r.p.m. for 10 min, resuspended in 1 ml ice-cold sodium citrate (0?02 M) and incubated on ice for 2 h. The lysate/cell mixture was spread on LK bottom agar plates containing 0?05 % (w/v) sodium citrate and 0?15 mg Em ml 21 , and was incubated at 37 uC for 90 min. The plates were overlaid with 5 ml LK top agar containing 25 mg Em ml 21 and 25 mg Lm ml 21 , and following setting, they were incubated at 37 uC until the appearance of putative phage transductants (18-72 h).
HL assays. All chemicals were purchased from Sigma unless otherwise stated. HL-deficient isolates were screened from strains with the w.t. phenotype by the plate assay of Grenier & Michaud (1993) . Briefly, BHI agar plates supplemented with HA (0?4 mg ml 21 ) were spot inoculated with several candidate colonies and incubated at 37 uC. Following growth, the plate was flooded with 10 % (w/v) cetylpyridinium chloride (BDH) and was left to stand at room temperature for 20-30 min. The cetylpyridinium chloride was then rinsed off the plate with distilled water. Colonies producing HL were surrounded by a zone of clearing.
HL in culture supernatants was assayed by measuring the production of N-acetylamino end-group sugars by the method of Reissig et al. (1955) . A standard curve was constructed for the subsequent determination of HL activity units. Briefly, 0?1 ml potassium tetraborate solution (0?8 M, pH 9?1) was mixed with 0?5 ml N-acetyl-Dglucosamine (NAG) standard sample (0?05-0?5 mmol ml 21 ) and with 0?5 ml distilled water. The samples were boiled for exactly 3 min and cooled immediately under cold water. Colour production was initiated by the addition of 3 where DA 544 represents the mean difference in absorbance between the two t 15 and the two t 0 readings from each sample, m represents the slope of the calibration curve, 3 is the dilution of the enzyme test sample (0?5 ml) in substrate solution (1 ml) and 1/15 represents the reciprocal of the amount of time the enzyme test samples were incubated with sodium hyaluronate at 37 uC (15 min). If samples were diluted before assaying, the enzyme activity was multiplied by the dilution factor. OD 600 was the measurement of cell culture density.
Pathogenicity study. The virulence of S. aureus strains was tested in an established murine abscess model of infection . S. aureus strains were grown in BHI to stationary phase (20 h) as described above. The bacteria were harvested and washed twice in an equal volume of ice-cold sterile PBS (pH 7?4). The concentration of the bacterial cells was adjusted to approximately 1610 8 c.f.u. ml 21 using a counting chamber (Thoma). Female, 5-to 8-week hairless mice (Harlan) were injected subcutaneously (n=12) with 0?2 ml of bacterial suspension. Serial dilutions of the samples were plated on BHI agar. The precise sizes of the inocula were confirmed by counting the resulting growth of colonies. After 7 days, the mice were killed and skin lesions were aseptically removed. Lesions destined for histological examination were measured and stored in sterile PBS supplemented with 10 % (v/v) formalin. The remaining lesions were measured, chopped and homogenized in 3 ml sterile ice-cold PBS in a mini-blender for approximately 5 min. The total number of bacteria recovered from the lesions was determined by viable cell count on BHI agar. Statistical significance of the data was evaluated by ANOVA. All values are reported as means ±95 % confidence limits.
Histology. Skin lesions were fixed in 10 % (w/v) formalin saline solution for 48 h and were then embedded in paraffin wax (Paraplast). Each wax-embedded lesion was sectioned (6 mm) using stainless steel microtome blades (RaLamb). A total of 10 sections per lesion were prepared, stained with haematoxylin and eosin using routine histological procedures (Bancroft & Stevens, 1996) and analysed by microscopy (Olympus BX40).
RESULTS AND DISCUSSION
Isolation of an S. aureus HL-deficient mutant A CLUSTAL W alignment of S. aureus HysA with the HLs from Streptococcus pneumoniae (L20670; Li et al., 2000) and Streptococcus agalactiae (U15050; Pritchard et al., 2000) showed that essential residues for the activity of the streptococcal enzymes are conserved in the S. aureus enzyme (data not shown). The ORF of hysA was disrupted in vitro by insertion of the 1?44 kb ermC gene, conferring erythromycin resistance, upstream of the putative HL active site. Following transformation of the TS shuttle vector pGM03 into S. aureus RN4220 and subsequently into 8325-4, its temperature sensitivity was checked by measuring the efficiency of plating on medium containing erythromycin at 30 uC (1?45610 9 c.f.u. ml 21 ) relative to 45 uC (9?4610 7 c.f.u. ml 21 ). Previous studies have shown that the pE194 ts replicon used in this work can be eliminated from cultures of S. aureus 8325-4 at temperatures of 40-43 u C (Greene et al., 1995; Luchansky et al., 1989) . Although it has previously been shown that plasmid pTS2tet, which also carries pE194 rep ts, can be eliminated from S. aureus RN4220 cells following growth at 43 uC for 15 mean cell generations (Adams, 1999) , plasmid pGM03 could still be prepared from 8325-4 cultures following the same incubation conditions (results not shown). Consequently, it was hypothesized that a higher incubation temperature would result in greater instability of pGM03. No substantial difference in growth rate was observed at 45 u C versus 43 u C (m=1?2 h 21 vs 1?3 h 21 ; t D = 0?55 h vs 0?54 h, respectively). Putative hysA : : ermC mutants of 8325-4 were identified on HA agar plates following elimination of the TS pGM03 (Fig. 1) . The structure of the hysA : : ermC locus was examined from mutant strains by Southern blot hybridization (Fig. 2) and PCR (results not shown). One isogenic mutant, HL-6, was chosen for further studies. Supernatants from hourly samples of strain HL-6, which was grown in batch culture, tested negative for HL production with the colorimetric assay (data not shown).
In vitro complementation of the HL deficiency
To verify whether the observed phenotype of strain HL-6 was due to the insertional inactivation of hysA by ermC, plasmid pGM04, a shuttle carrying the active hysA gene, was transformed into HL-6. All the isolates that grew on Cm+Em plates and were subcultured on HA-containing HL _ 6 w.t. Fig. 1 . HL plate assay. HL produced by an S. aureus culture carrying the active hysA gene diffuses into the medium surrounding the growth, breaking down the HA present in the medium. Upon addition of cetylpyridinium chloride (10 %, w/v), HA precipitates, leaving a clear zone around the growth (w.t.). No clearing zone is observed around the growth arising from mutant strain HL-6. medium tested positive for HL production (data not shown).
Transduction of the hysA : : ermC allele
The hysA : : ermC mutation present on the chromosome of HL-6 was transduced to the w.t. 8325-4 strain via w11. The expression of the ermC gene was initially induced with low levels of Em. However, in order to minimize the selection of point mutations for Em, the cells were screened on Lm as well as Em. Two transductants, HL-13T and HL-16T, were isolated and their identity was verified using the Pastorex Staph-Plus (PSP) latex agglutination test (Bio-Rad). Culture supernatants from both isolates were HL negative when tested with the plate and the colorimetric assays (data not shown).
Growth characteristics of staphylococcal strains
The growth characteristics, i.e. maximum specific growth rate (m max ) and growth yield, of HL-6, HL-13T and HL-16T were compared to those of the w.t. strain during growth in BHI medium. All four strains reached a maximum specific growth rate of 1?4 h 21 . In addition, they reached similar growth yields, which ranged between 10 and 12 OD 600 units.
Virulence studies with HL-deficient mutants
In order to determine whether HL is a virulence factor of S. aureus, mice were challenged subcutaneously with strains 8325-4 (w.t.) and HL-6. Following the 7 day infection period the majority of the animals challenged with the w.t. strain developed a red, open and crusty lesion. In contrast, the HL-negative strain caused a less severe white, raised pustule (Fig. 3) . These results suggested a role for HL in subcutaneous infections.
Microscopic examination of stained sections from infected areas revealed clear histopathological signs of inflammatory response, characterized by the presence of pus in the centre of the lesion and cellular infiltration mainly to the periphery (Fig. 4a ). Closer inspection showed that in some lesions the infiltrate was composed mainly of mononuclear cells while in others of numerous neutrophils (Fig. 4b ). Despite the differences in the gross appearance of the lesions produced by the w.t. and HL-6 strains, no clear differences in the types of inflammatory infiltrate were observed between the lesions of the two animal groups (Fig. 4a) These results strongly suggest that the disruption of the hysA gene of S. aureus has a negative effect on the degree of pathology caused by the organism.
Role of global regulators agr and sar on HL production
Although, to date, there are no reports on the role of the agr and sar loci in the regulation of HL, the results of previous studies by Taylor & Holland (1991) and Rogers (1954) suggest that its regulation is distinct from that of other S. aureus exoproteins, such as toxic shock syndrome toxin-1 (TSST-1), which are expressed during late exponential phase.
The w.t. S. aureus 8325-4 strain and its derivatives, WA250 (agr) and PC1839 (sar), were grown in CDM in the absence of selection. HL activity and OD 600 were measured as described in Methods. Although the three strains had similar growth kinetics (Fig. 5) , strain WA250 demonstrated approximately a 16-fold reduction in HL activity compared to the w.t. (0?9 vs 14?0 specific activity units per OD 600 unit). In contrast, strain PC1839 exhibited a 35fold (487 specific activity units per OD 600 unit) increased activity compared to the w.t. It is of interest that the activity from all three strains decreased to undetectable levels during the post-exponential phase of growth. It is possible that proteases in the supernatant fluid may cleave HL posttranslationally, thus reducing its activity. This effect was exaggerated in the sar strain, in which although HL specific activity was the highest of the strains tested, it diminished at the highest rate. Previous investigations have reported that proteases, which are overexpressed in the sarA mutant strain PC1839, are responsible for the inactivation of a-haemolysin in the same strain (Lindsay & Foster, 1999) . However, additional factors may be responsible for this observed decrease in HL specific activity since it occurred even in the agr mutant strain, which is expected to have a reduced protease production.
These observations indicate that sar and agr, two global virulence modulators, downregulate and upregulate respectively HL production. This provides further evidence of the involvement of HL in virulence of S. aureus. However, HL production, as observed by in vitro experiments, appears to be different from that of other staphylococcal exoproteins in that it occurs during the early to mid-exponential phases of growth. This observation strengthens the argument for involvement of HL in the early stages of infection.
The results presented in this work were obtained using the standard laboratory S. aureus strain 8325-4, which is (agr) and (c) PC1839 (sar) S. aureus 8325-4 were grown in CDM as described in Methods. $, ln OD 600 for the strain under investigation; $, ln OD 600 for w.t. used during the same experiment; #, HL specific activity (10 3 6mmol NAG released ml "1 min "1 per OD 600 unit). Note that the y-axis scale is different for (a), (b) and (c). defective for rsbU, the gene required for the activation of s B . The results were therefore obtained in the absence of s B function and hence may not be representative of the behaviour of a true w.t. clinical strain. However, since strain 8325-4 has been used for much work on the regulation of virulence of S. aureus, it is important that the regulation of HL be analysed in this background for comparative purposes. Furthermore, the results obtained from in vivo experiments using the isogenic hysA 2 mutant are valid because the positive control w.t. 8325-4 strain was of an identical genomic background apart from the hysA gene. Future work should investigate the regulation of HL in an rsbU + derivative of S. aureus 8325-4. Such a derivative has recently been described by Horsburgh et al. (2002) .
